Definium Therapeutics, Inc. Common Shares (DFTX) Ownership & Trading Activity

Institutional holders, insider transactions, and congressional trades for DFTX. 13F holdings as of 2026-06-30.

In 13F filings for the quarter ended June 30, 2026, 348 institutions reported holding DFTX, with 114.8 million shares worth $5.3 billion in aggregate.

Top Institutional Holders

InstitutionSharesValueChange
BlackRock11,232,834$528MINCREASED
Capital Group8,331,133$392MNEW
Avoro Capital Advisors7,188,888$338MINCREASED
Driehaus Capital Management6,845,276$322MINCREASED
Janus Henderson (Jupiter Topco)5,615,645$264MINCREASED

Recent Insider Trades

InsiderTypeSharesValueDate
Daniel Karlin (Chief Medical Officer)SELL10,853$397K2026-09-25
Robert Barrow (Chief Executive Officer)SELL31,550$1M2026-09-25
Matthew T. Wiley (Chief Commercial Officer)SELL3,097$113K2026-09-25
Mark Sullivan (Chief Legal Officer)SELL14,051$514K2026-09-25
Brandi Roberts (Chief Financial Officer)SELL3,377$123K2026-09-25

Full institutional holdings, insider history, and congressional trades for Definium Therapeutics, Inc. Common Shares on SentiSense.